UnitedHealth Group Inc (UNH) stock analysis and fair value
UNH · NYSE · Healthcare
379,30 US$
▲ +2,25%
In 30 seconds
The business. Healthcare. Sells 447,6 B US$ a year, keeps 3% as profit and sales grow 11,7% a year (last 5 years).
The price. At its usual price: you pay 29x earnings, close to its normal (26x).
Strength. Passes 6 of 8 quality checks, but debt weighs: 4,0 years of profit.
UNH fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueUnitedHealth Group Inc key numbers
- Market cap
- 344,5 B US$
- P/E (price ÷ earnings)
- 28,7
- Dividend yield
- 2,30%
- Revenue growth
- 10,3%
- a year, over 9 years
- Profit margin
- 2,7%
- Quality checks
- 6/8
Fiscal 2025 financials, as filed with the SEC.
What analysts say
Buy
27 of 34 analysts recommend buying.
See everything about UNH on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector